miR-155 expression level changes might be associated with initial phases of breast cancer pathogenesis and lymph-node metastasis

Abstract

Our results suggest that miR-155 might be involved in breast cancer pathogenesis and in tumor spreading to the lymph nodes, and that it might be used as biomarker for additional stratification of patients with invasive breast carcinomas with non-invasive component.